Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL.

<h4>Objectives</h4>The objective of this study was to evaluate a patient navigation (PN) program that attempts to reduce the time between a breast cancer screening abnormality and definitive diagnosis among medically underserved populations of Tampa Bay, Florida.<h4>Methods</h4&...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ji-Hyun Lee, William Fulp, Kristen J Wells, Cathy D Meade, Ercilia Calcano, Richard Roetzheim
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f55516f7d69e42b29f5f10ae5f4a20ad
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f55516f7d69e42b29f5f10ae5f4a20ad
record_format dspace
spelling oai:doaj.org-article:f55516f7d69e42b29f5f10ae5f4a20ad2021-11-18T08:55:03ZPatient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL.1932-620310.1371/journal.pone.0074542https://doaj.org/article/f55516f7d69e42b29f5f10ae5f4a20ad2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24066145/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objectives</h4>The objective of this study was to evaluate a patient navigation (PN) program that attempts to reduce the time between a breast cancer screening abnormality and definitive diagnosis among medically underserved populations of Tampa Bay, Florida.<h4>Methods</h4>The Moffitt Patient Navigation Research Program conducted a cluster randomized design with 10 primary care clinics. Patients were navigated from time of a breast screening abnormality to diagnostic resolution. This paper examined the length of time between breast abnormality and definitive diagnosis, using a shared frailty Cox proportional hazard model to assess PN program effect.<h4>Results</h4>1,039 patients were eligible for the study because of an abnormal breast cancer screening/clinical abnormality (494 navigated; 545 control). Analysis of PN effect by two time periods of resolution (0-3 months and > 3 months) showed a lagged effect of PN. For patients resolving in the first three months, the adjusted Hazard Ratio (aHR) was 0.85 (95% Confidence Interval [CI]: 0.64-1.13) suggesting that PN had no effect on resolution time during this period. Beyond three months, however, navigated patients resolved more quickly to diagnostic resolution compared with the control group (aHR 2.8, 95%CI: 1.30-6.13). The predicted aHR at 3 months was 1.2, which was not statistically significant, while PN had a significant positive effect beyond 4.7 months.<h4>Conclusions</h4>PN programs may increase the timeliness of diagnostic resolution for patients with a breast cancer-related abnormality. PN did not speed diagnostic resolution during the initial three months of follow up but started to reduce time to diagnostic resolution after three months and showed a significant effect after 4.7 months.<h4>Trial registration</h4>ClinicalTrials.gov NCT00375024.Ji-Hyun LeeWilliam FulpKristen J WellsCathy D MeadeErcilia CalcanoRichard RoetzheimPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e74542 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ji-Hyun Lee
William Fulp
Kristen J Wells
Cathy D Meade
Ercilia Calcano
Richard Roetzheim
Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL.
description <h4>Objectives</h4>The objective of this study was to evaluate a patient navigation (PN) program that attempts to reduce the time between a breast cancer screening abnormality and definitive diagnosis among medically underserved populations of Tampa Bay, Florida.<h4>Methods</h4>The Moffitt Patient Navigation Research Program conducted a cluster randomized design with 10 primary care clinics. Patients were navigated from time of a breast screening abnormality to diagnostic resolution. This paper examined the length of time between breast abnormality and definitive diagnosis, using a shared frailty Cox proportional hazard model to assess PN program effect.<h4>Results</h4>1,039 patients were eligible for the study because of an abnormal breast cancer screening/clinical abnormality (494 navigated; 545 control). Analysis of PN effect by two time periods of resolution (0-3 months and > 3 months) showed a lagged effect of PN. For patients resolving in the first three months, the adjusted Hazard Ratio (aHR) was 0.85 (95% Confidence Interval [CI]: 0.64-1.13) suggesting that PN had no effect on resolution time during this period. Beyond three months, however, navigated patients resolved more quickly to diagnostic resolution compared with the control group (aHR 2.8, 95%CI: 1.30-6.13). The predicted aHR at 3 months was 1.2, which was not statistically significant, while PN had a significant positive effect beyond 4.7 months.<h4>Conclusions</h4>PN programs may increase the timeliness of diagnostic resolution for patients with a breast cancer-related abnormality. PN did not speed diagnostic resolution during the initial three months of follow up but started to reduce time to diagnostic resolution after three months and showed a significant effect after 4.7 months.<h4>Trial registration</h4>ClinicalTrials.gov NCT00375024.
format article
author Ji-Hyun Lee
William Fulp
Kristen J Wells
Cathy D Meade
Ercilia Calcano
Richard Roetzheim
author_facet Ji-Hyun Lee
William Fulp
Kristen J Wells
Cathy D Meade
Ercilia Calcano
Richard Roetzheim
author_sort Ji-Hyun Lee
title Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL.
title_short Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL.
title_full Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL.
title_fullStr Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL.
title_full_unstemmed Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL.
title_sort patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, tampa, fl.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/f55516f7d69e42b29f5f10ae5f4a20ad
work_keys_str_mv AT jihyunlee patientnavigationandtimetodiagnosticresolutionresultsforaclusterrandomizedtrialevaluatingtheefficacyofpatientnavigationamongpatientswithbreastcancerscreeningabnormalitiestampafl
AT williamfulp patientnavigationandtimetodiagnosticresolutionresultsforaclusterrandomizedtrialevaluatingtheefficacyofpatientnavigationamongpatientswithbreastcancerscreeningabnormalitiestampafl
AT kristenjwells patientnavigationandtimetodiagnosticresolutionresultsforaclusterrandomizedtrialevaluatingtheefficacyofpatientnavigationamongpatientswithbreastcancerscreeningabnormalitiestampafl
AT cathydmeade patientnavigationandtimetodiagnosticresolutionresultsforaclusterrandomizedtrialevaluatingtheefficacyofpatientnavigationamongpatientswithbreastcancerscreeningabnormalitiestampafl
AT erciliacalcano patientnavigationandtimetodiagnosticresolutionresultsforaclusterrandomizedtrialevaluatingtheefficacyofpatientnavigationamongpatientswithbreastcancerscreeningabnormalitiestampafl
AT richardroetzheim patientnavigationandtimetodiagnosticresolutionresultsforaclusterrandomizedtrialevaluatingtheefficacyofpatientnavigationamongpatientswithbreastcancerscreeningabnormalitiestampafl
_version_ 1718421178870136832